Eczema drug study pulled before it began
NCT ID NCT04761978
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study was designed to check how well JAK inhibitors work and how safe they are for adults with moderate-to-severe eczema. It planned to track skin improvement, itching, sleep loss, and side effects in a real-world setting in France. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hop Claude Huriez Chu Lille
Lisle-sur-Tarn, 59037, France
Conditions
Explore the condition pages connected to this study.